Drugmaker Cuts Wegovy Price, but Doctors Still See Cost Challenges for Patients

(MedPage Today) — Novo Nordisk is chopping prices again for semaglutide (Wegovy), but doctors say the expense will remain challenging for patients without insurance.
The drugmaker said Monday that it has started selling higher doses of the injectable…